Skip to main content

Advertisement

Log in

A chloroacetamide derivative as a potent candidate for fusariosis treatment

  • Clinical Microbiology - Research Paper
  • Published:
Brazilian Journal of Microbiology Aims and scope Submit manuscript

Abstract

Fusariosis has presented a significant increase in their incidence in the last years. This epidemiological panorama probably is due to the increasing profile of refractory susceptibility of Fusarium spp. to available drugs, especially in immunocompromised individuals. Thus, the development of new compounds with effectiveness on these organisms is a necessity. This study evaluated the antifungal potential of a chloroacetamide derivative (4-BFCA) against resistant Fusarium strains. As a result, the compound was effective against all strains (MIC range 12.5–50 μg/mL). The time kill assay demonstrated that 4-BFCA presents a concentration-dependent fungicidal action. Although its action mechanism has not yet been elucidated, it was possible to observe its efficacy through damages and alterations provoked along the hyphae of Fusarium spp. 4-BFCA maintained a high survival rate of Tenebrio molitor larvae, suggesting that it does not cause acute systemic toxicity on this host at the concentration evaluated. In addition, 4-BFCA was 83.33% effective in combating a fungal infection in vivo on the chorioallantoid membrane of embryonated eggs. Our results are very promising and arouse interest to investigate the action of 4-BFCA on Fusarium strains since it acts as a possible candidate for the development of new therapies for the treatment of fusariosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5

Similar content being viewed by others

References

  1. Nucci F, Nouér SA, Capone D, Anaissie E, Nucci M (2015) Fusariosis. Semin Respir. Crit Care 36:706–714

    Google Scholar 

  2. Debourgogne A, Dorin J, Machouart M (2016) Emerging infections due to filamentous fungi in humans and animals: only the tip of the iceberg? Environ Microbiol 8:332–342

    Google Scholar 

  3. Diongue K, Ndiaye M, Seck MC, Diallo MA, Badiane AS, Ndiaye D (2017) Onychomycosis caused by Fusarium spp. in Dakar, Senegal: epidemiological, clinical, and mycological study. Dermatol Res Pract 2017:4.

  4. Gupta C, Jongman M, Das S, Snehaa K, Bhattacharya SN, Seyedmousavi S, Van Diepeningen AD (2016) Mycopathologia 181:497–504

    Article  CAS  Google Scholar 

  5. Al-Hatmi AMS, Curfs-Breuker I, De Hoog GS, Meis JF, Verweij PE (2017) Antifungal susceptibility testing of Fusarium: a practical approach. J Fungi 3:19

    Article  Google Scholar 

  6. Batista BG, Dalla Lana DF, Silveira GP, SA MM, Ferreira M, Russo TVC, Canto RFS, Barbosa FAR, Braga AL, Kaminski TFA, De Oliveira LFS, Machado MM, Lopes W, Vainstein MH, Teixeira ML, Andrade SF, Fuentefria AM (2017) Allylic selenocyanates as new agents to combat Fusarium involved with human infections. ChemistrySelecty 2:11926–11932

    Article  CAS  Google Scholar 

  7. Taj-Aldeen SJ (2017) Reduced multidrug susceptibility profile is a common feature of opportunistic fusarium species: Fusarium multi-drug resistant pattern. J Fungi 3:18

    Article  Google Scholar 

  8. Rosa PD, Heidrich D, Corrêa C, Scroferneker ML, Vettorato G, Fuentefria AM, Goldani LZ (2017) Genetic diversity and antifungal susceptibility of Fusarium isolates in onychomycosis. Mycoses 60:616–622

    Article  Google Scholar 

  9. Costa MI, Vilugron Rodrigues FAV, Vieira FF, Jarros IC, Kischkel B, Negri M, Becker TCA, Svidzinski TIE (2019) Effects of intratracheal Fusarium solani inoculation in immunocompetent mice. Microb Pathog 128:317–322

    Article  Google Scholar 

  10. Van Diepeningen AD, Al-Hatmi AMS, Brankovics B, De Hoog GS (2014) Taxonomy and clinical spectra of Fusarium species: where do we stand in 2014? Curr Clin Microbiol Rep 1:10–18

    Article  Google Scholar 

  11. Dabas Y, Bakhshi S, Xess I (2016) Fatal cases of bloodstream infection by Fusarium solani and review of published literature. Mycopathologia 181:291–296

    Article  Google Scholar 

  12. Stempel JM, Hammond SP, Sutton DA, Weiser LM, Marty FM (2015) Invasive fusariosis in the voriconazole era: single-center 13-year experience. Open Forum Infect Dis 2:ofv099

    Article  Google Scholar 

  13. Ersal T, Al-Hatmi ASM, Cilo DB, Curfs-Breuker I, Meis JF, Özkalemkaş F, Ener B, Van Diepeningen AD (2015) Fatal disseminated infection with Fusarium petroliphilum. Mycopathologia 179:119–124

    Article  Google Scholar 

  14. McCarthy MW, Denning DW, Walsh T (2017) Future research priorities in fungal resistance. J Infec Dis 216:484–492

    Article  Google Scholar 

  15. Wiederhold NP (2017) Antifungal resistance: current trends and future strategies to combat. Infect Drug Resist 10:249–259

    Article  CAS  Google Scholar 

  16. Katke SA, Amrutkar SV, Bhor RJ, Khairnar MV (2011) Synthesis of biologically active 2-chloro-N-alkyl/arylacetamide derivatives. Int J Pharm Sci Res 2:148–156

    CAS  Google Scholar 

  17. Karier P, Kraus G, Kolbe I (2017) Metazachlor traces in the main drinking water reservoir in Luxembourg: a scientific and political discussion. Environ Sci Eur 29:25

    Article  Google Scholar 

  18. Marco-Contelles J, Gomez-Sanchez E (2005) New agents with antimycobacterial activity. Arch Pharm 338:562–563

    Article  CAS  Google Scholar 

  19. Aschale M (2012) Synthesis and antimicrobial evaluation of some novel substituted 2-chloroacetanilides. Int J Chemtech Res 4:437–1441

    Google Scholar 

  20. Machado GRM, De Andrade SF, Pippi B, Bergamo VZ, Berlitz SJ, Lopes W, Lavorato SN, Külkamp-Guerreiro IC, Vainstein MH, Teixeira ML, Alves RJ, Fuentefria AM (2019) Chloroacetamide derivatives as a promising topical treatment for fungal skin infections. Mycologia 111:612–623

    Article  Google Scholar 

  21. Lavorato SN, Duarte MC, De Andrade PHR, Coelho EAF, Alves RJ (2016) Synthesis, antileishmanial activity and QSAR studies of 2-chloro-N-arylacetamides. Braz J Pharm Sci 53:e16067

    Google Scholar 

  22. Harte AJ (2006) Gunnlaugsson T. Synthesis of α-chloroamides in water. Tetrahedron Lett 47:6321–6324

    Article  CAS  Google Scholar 

  23. Singh DCP, Hashim SR, Singhal RG (2011) Synthesis and antimicrobial activity of some new thioether derivatives of quinoxaline. E-J Chem 8:635–642

    Article  CAS  Google Scholar 

  24. Clinical and Laboratory Standards Institute (CLSI) (2008) Reference method for broth dilution antifungal susceptibility testing of filamentous fungi; Approved Standard, 2ed edn. Wayne, PA: CLSI Document M38-A2. Clinical Laboratory Standards Institute.

  25. Gill TA, Li J, Saenger M, Scofield SR (2016) Thymol-based submicron emulsions exhibit antifungal activity against Fusarium graminearum and inhibit Fusarium head blight in wheat. J Appl Microbiol 121:1103–1116

    Article  CAS  Google Scholar 

  26. Joubert LM, Ferreira JAG, Stevens DA, Cegelski L (2015) Aspergillus fumigates biofilms: a comparison of processing techniques for scanning electron microscopy of fungal mycelium and extracellular matrix. Microsc Microanal 21:935–936

    Article  Google Scholar 

  27. De Souza PC, Morey AT, Castanheira GM, Bocate KP, Panagio LA, Ito FA, Almeida RS (2015) Tenebrio molitor (Coleoptera: Tenebrionidae) as an alternative host to study fungal infections. J Microbiol Methods 118:182–186

    Article  Google Scholar 

  28. Usui K, Nishida S, Sugita T, Ueki T, Matsumoto Y, Okumura H, Sekimizu K (2016) Acute oral toxicity test of chemical compounds in silkworms. Drug Discov Ther 10:57–61

    Article  CAS  Google Scholar 

  29. Rodrigues A, Pina Vaz C, Fonseca AF, De-Oliveira JM (1993) Evaluating the concentration of a Candida albicans suspension. Infect Dis Obstet Gyneco 1:134–136

    Article  CAS  Google Scholar 

  30. Jacobsen ID, Grobe K, Slesiona S, Hube B, Berndt A, Brock M (2010) Embryonated eggs as an alternative infection model to investigate Aspergillus fumigatus virulence. Infect Immun 78:2995–3006

    Article  CAS  Google Scholar 

  31. Dalla Lana DF, Giuliani LM, Reolon JB, Lopes W, Vainstein MH, Danielli LJ et al (2018) Nanoemulsion improves the antifungal activity of allylic thiocyanates against yeasts and filamentous pathogenic fungi. ChemistrySelect 3:11663–11670

    Article  CAS  Google Scholar 

  32. Liebert MA (1991) Final report on the safety assessment of chloroacetamide. J Am Coll Toxicol 10:21–22

    Article  Google Scholar 

  33. Food and Drug Administration (FDA) (1987) Cosmetic product formulation data for Chloroacetamide. FDA Computer Printout.

  34. ANVISA website. Available in http://portal.anvisa.gov.br/documents/10181/3285739/RDC_29_2012_.pdf/c74fbb1a c98b 4899–81ae-7ad9e18d807e. [accessed 25 March 2020].

  35. Corrêa JCR, Salgado HRN (2011) Review of fluconazole properties and analytical for its determination. Crit Ver Anal Chem 4:270–279

    Article  Google Scholar 

  36. Crowley PD, Gallagher HC (2014) Clotrimazole as a pharmaceutical: past, present and future. J Appl Microbiol 1:611–617

    Article  Google Scholar 

  37. Kovacic P, Cooksy A (2012) Novel, unifying mechanism for amphotericin B and other polyene drugs: electron affinity, radicals, electron transfer, autoxidation, toxicity, and antifungal action. MedChemComm 3:274–328

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank the Brazilian agencies Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES), Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq), and Fundação de Amparo à Pesquisa do Estado do Rio Grande do Sul (FAPERGS – EDITAL 04/2016 – PRONUPEQ 2016) for financial support and research fellowships. Alexandre Meneghello Fuentefria is grateful to Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq) for the PQ fellowships (Edital Universal 2018).

Author information

Authors and Affiliations

Authors

Contributions

Gabriella da Rosa Monte Machado participated in the conceptualization, methodology, software, validation, formal analysis, investigation, data curation, writing—original draft preparation, and writing—review and editing of the text. Stefânia Neiva Lavorato participated in the methodology, validation, formal analysis, and data investigation. William Lopes and Mário Teixeira participated in the methodology, data curation, and formal analysis. The professors Marilene Henning Vainstein, Ricardo José Alves, Saulo Fernandes de Andrade, and Alexandre Meneghello Fuentefria participated in the visualization, supervision, project administration, and acquisition of the financial support.

Corresponding author

Correspondence to Gabriella da Rosa Monte Machado.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher's note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Responsible Editor: Carlos Pelleschi Taborda

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

da Rosa Monte Machado, G., Neiva Lavorato, S., Lopes, W. et al. A chloroacetamide derivative as a potent candidate for fusariosis treatment. Braz J Microbiol 53, 1289–1295 (2022). https://doi.org/10.1007/s42770-022-00771-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s42770-022-00771-9

Keywords

Navigation